Infosys Innovation Fund backs Basel's Indivi in early VC round
What's the deal? Basel-based TechBio company Indivi has secured strategic investment from the Infosys Innovation FundDealroom has a profile for this one. Try Dealroom → in an early-stage round announced in August 2026. The amount was not disclosed.
What does Indivi do? Its platform uses smartphone-based assessments of motor and cognitive function to support earlier detection of treatment effects in neuroscience clinical trials, starting with Parkinson's disease.
What's the money for? The investment will help Indivi scale its commercial organisation and deploy the platform across more neuroscience clinical programmes and biopharma partners.
Why it matters. The investment builds on a strategic collaboration announced by InfosysDealroom has a profile for this one. Try Dealroom → and Indivi in May 2025, combining Infosys' artificial intelligence, machine learning and wearable-sensor capabilities with Indivi's expertise in neuroscience and digital biomarkers.
Read more: Startup Ticker
Image credit: Generated with Gemini
